SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-033282
Filing Date
2015-04-08
Accepted
2015-04-08 21:10:37
Documents
2
Period of Report
2015-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2950
2 EX-24 DOCUMENT attachment1.htm EX-24 4633
  Complete submission text file 0001209191-15-033282.txt   9126
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARBYLAN THERAPEUTICS, INC. 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address
Renzi David (Reporting) CIK: 0001631294 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 15760218